FDA inspection
Invitrx Therapeutics: FDA inspection ending Sep 18, 2019
FDA inspection 1102160 · Official Action Indicated (OAI) · San Juan, PR
Key facts
| Inspection ID | 1102160 |
|---|---|
| Firm | Invitrx Therapeutics |
| FEI number | 3015766791 |
| Address | Upr Comprehensive Cancer Grounds Of Medical Center |
| City | San Juan |
| State | PR |
| ZIP | 00935 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Sep 18, 2019 |
| Classification | Official Action Indicated (OAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data